KCT0003511
Recruiting
未知
Developing personalized cancer therapy strategy through genomic analysis in liquid biopsy and cancer tissue from metastatic gastrointestinal cancer patients
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- Pusan National University Hospital
- Enrollment
- 210
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients with gastrointestinal cancer who have metastasis and who have no other treatment besides chemotherapy are enrolled in this study.
- •Control group: 1\) Among patients diagnosed with gastrointestinal cancer histologically, patients without metastasis
- •2\) patients with gastrointestinal diseases without cancer
Exclusion Criteria
- •Patients who refused chemotherapy
- •Under 18 age
- •A patient with intellectual disability
- •Control group: ECOG 3\-4, Under 18 age, A patient with intellectual disability
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Towards patient tailored cancer treatment supported by molecular imaging IMPACT: IMaging PAtients for Cancer drug selecTion - Metastatic Breast Cancermammacarcinomametastatic breast cancer10006291NL-OMON41527niversitair Medisch Centrum Groningen200
Active, not recruiting
Not Applicable
Imaging patients for cancer drug selection - metastatic breast cancerMetastatic Breast CancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2013-000551-41-NLniversity Medical Center Groningen
Completed
Not Applicable
Pharmacotherapy Personalization of Cancer PatientsHead and Neck NeoplasmsOncologic PatientsNCT04866498Poznan University of Medical Sciences22
Terminated
Not Applicable
Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon CancerMedullary Thyroid CancerColon CancerNCT02363647Icahn School of Medicine at Mount Sinai10
Unknown
Not Applicable
Personalized Sequence for Thoracic, Esophageal, and H&N CancerLung CancerNCT02299622Samsung Medical Center200